Skip to content
Facebook Instagram Linkedin

LifeScienceHistory.com

History made daily

  • Home
  • DirectoryExpand
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • News and History
  • Cartoons
  • Small World
  • Earth is a RockExpand
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
LifeScienceHistory.com
History made daily
Home / pandemic - Page 73

pandemic

Duke-NUS, GenScript and A*STAR launched first-in-the-world SARS-CoV-2 serology test
COVID-19 | Life Science History

Duke-NUS, GenScript and A*STAR launched first-in-the-world SARS-CoV-2 serology test

On May 15, 2020, Duke-NUS Medical School, GenScript Biotech, and the Diagnostics Development Hub at Singapore’s Agency for…

Read More Duke-NUS, GenScript and A*STAR launched first-in-the-world SARS-CoV-2 serology testContinue

CIRM board approved clinical trials targeting COVID-19 and sickle cell disease
Biotechnology | COVID-19 | Non-Profit Research | Therapeutics

CIRM board approved clinical trials targeting COVID-19 and sickle cell disease

On May 15, 2020, the California Institute for Regenerative Medicine (CIRM) board approved new clinical trials for COVID-19…

Read More CIRM board approved clinical trials targeting COVID-19 and sickle cell diseaseContinue

Abbott provided update on ID NOW
Biotechnology | COVID-19

Abbott provided update on ID NOW

On May 14, 2020, Abbott’s ID NOW announced that was further clarifying product information to provide better guidance…

Read More Abbott provided update on ID NOWContinue

The  FDA informed public about possible accuracy concerns with Abbott ID NOW point-of-care test
COVID-19 | FDA | Life Science History

The FDA informed public about possible accuracy concerns with Abbott ID NOW point-of-care test

On May 14, 2020, the FDA alerted the public to early data that suggest potential inaccurate results from…

Read More The FDA informed public about possible accuracy concerns with Abbott ID NOW point-of-care testContinue

Abivax received ANSM and ethics committee clearance to test its development candidate ABX464 in 1,034 Covid-19 patients in randomized phase 2b/3 clinical trial
COVID-19 | Life Science History

Abivax received ANSM and ethics committee clearance to test its development candidate ABX464 in 1,034 Covid-19 patients in randomized phase 2b/3 clinical trial

On May 14, 2020 Abivax announced it had received clearance from Franceメs National Agency for the Safety of…

Read More Abivax received ANSM and ethics committee clearance to test its development candidate ABX464 in 1,034 Covid-19 patients in randomized phase 2b/3 clinical trialContinue

Vyriad announced development of new antibody test to determine protective immunity from COVID-19
COVID-19 | Life Science History

Vyriad announced development of new antibody test to determine protective immunity from COVID-19

On May 14, 2020 Vyriad announced that it had completed the development of a serology test to measure…

Read More Vyriad announced development of new antibody test to determine protective immunity from COVID-19Continue

Countries begin large-scale screening for SARS-CoV-2 in sewage
Biotechnology | COVID-19 | Diagnostics

Countries begin large-scale screening for SARS-CoV-2 in sewage

On May 14, 2020,The Scientist reported that researchers from several countries including the US, Switzerland, Italy, the Netherlands,…

Read More Countries begin large-scale screening for SARS-CoV-2 in sewageContinue

First detailed analysis of immune response to SARS-CoV-2 bodes well for COVID-19 vaccine development
COVID-19 | Life Science History | Vaccine

First detailed analysis of immune response to SARS-CoV-2 bodes well for COVID-19 vaccine development

On May 14, 2020, scientists at La Jolla Institute for Immunology (LJI) announced they had resolved the uncertainty…

Read More First detailed analysis of immune response to SARS-CoV-2 bodes well for COVID-19 vaccine developmentContinue

AIM ImmunoTech announced FDA authorization for first human ampligen trial in COVID-19 patients with cancer
COVID-19 | FDA | Life Science History

AIM ImmunoTech announced FDA authorization for first human ampligen trial in COVID-19 patients with cancer

On May 14, 2020, AIM ImmunoTech announced the FDA authorized the first human trial assessing the safety and…

Read More AIM ImmunoTech announced FDA authorization for first human ampligen trial in COVID-19 patients with cancerContinue

University of Alberta researchers launched a joint effort with US-based Tonix Pharma to develop and test a vaccine against COVID-19
Biotechnology | COVID-19 | Genomics | Non-Profit Research | Vaccine

University of Alberta researchers launched a joint effort with US-based Tonix Pharma to develop and test a vaccine against COVID-19

On May 13, 2020, University of Alberta (UA) researchers launched a joint effort with U.S.-based Tonix Pharmaceuticals to…

Read More University of Alberta researchers launched a joint effort with US-based Tonix Pharma to develop and test a vaccine against COVID-19Continue

Philips received FDA clearance for use of ultrasound portfolio to manage COVID-19-related lung and cardiac complications
COVID-19 | FDA | Life Science History

Philips received FDA clearance for use of ultrasound portfolio to manage COVID-19-related lung and cardiac complications

On May 13, 2020, Royal Philips announced that it had received 510(k) clearance from the FDA to market…

Read More Philips received FDA clearance for use of ultrasound portfolio to manage COVID-19-related lung and cardiac complicationsContinue

Thermo Fisher Scientific response to COVID-19 expanded to include new serology test
Biotechnology | COVID-19 | Diagnostics | FDA | Non-Profit Research

Thermo Fisher Scientific response to COVID-19 expanded to include new serology test

On May 13, 2020, Thermo Fisher Scientific announced it will expand its response to the COVID-19 pandemic by…

Read More Thermo Fisher Scientific response to COVID-19 expanded to include new serology testContinue

University of Nebraska developed a COVID-19 screening mobile app
COVID-19 | Life Science History

University of Nebraska developed a COVID-19 screening mobile app

On May 13, 2020, a new protective device that is expected to help protect healthcare workers everywhere from…

Read More University of Nebraska developed a COVID-19 screening mobile appContinue

Catalent signed development agreement with Ennaid Therapeutics on its COVID-19 lead program
COVID-19 | Life Science History

Catalent signed development agreement with Ennaid Therapeutics on its COVID-19 lead program

On May 13, 2020,Catalent announced a collaboration with Ennaid Therapeutics to develop an oral, antiviral treatment targeted at…

Read More Catalent signed development agreement with Ennaid Therapeutics on its COVID-19 lead programContinue

Immunic received regulatory approval from German Health Authority BfArM to initiate phase 2 clinical trial in COVID-19 patients
COVID-19 | Life Science History

Immunic received regulatory approval from German Health Authority BfArM to initiate phase 2 clinical trial in COVID-19 patients

On May 13, 2020, Immunic announced it had received first regulatory approval from Germany’s BfArM to initiate a…

Read More Immunic received regulatory approval from German Health Authority BfArM to initiate phase 2 clinical trial in COVID-19 patientsContinue

Study confirmed cats can become infected with and may transmit COVID-19 to other cats
Biotechnology | COVID-19 | Diagnostics | Non-Profit Research | Veterinary

Study confirmed cats can become infected with and may transmit COVID-19 to other cats

On May 13, 2020, in a study published in the New England Journal of Medicine, scientists in the…

Read More Study confirmed cats can become infected with and may transmit COVID-19 to other catsContinue

National Research Council of Canada and CanSino Biologics announced collaboration to advance vaccine against COVID-19
Biotechnology | COVID-19 | Non-Profit Research | Vaccine

National Research Council of Canada and CanSino Biologics announced collaboration to advance vaccine against COVID-19

On May 12, 2020, the National Research Council of Canada (NRC) announced a collaboration with CanSino Biologics to…

Read More National Research Council of Canada and CanSino Biologics announced collaboration to advance vaccine against COVID-19Continue

Abbott received FDA Emergency Use Authorization for COVID-19 Molecular Test on New Alinity mル System
COVID-19 | FDA | Life Science History

Abbott received FDA Emergency Use Authorization for COVID-19 Molecular Test on New Alinity mル System

On May 12, 2020, Abbott announced the FDA issued an Emergency Use Authorization (EUA) for the company’s molecular…

Read More Abbott received FDA Emergency Use Authorization for COVID-19 Molecular Test on New Alinity mル SystemContinue

National Research Council of Canada and USasks VIDO-InterVac collaborated to advance development of vaccine against COVID-19
Biotechnology | COVID-19 | Non-Profit Research | Therapeutics | Vaccine

National Research Council of Canada and USasks VIDO-InterVac collaborated to advance development of vaccine against COVID-19

On May 12, 2020, the National Research Council of Canada (NRC) and the University of Saskatchewan’s (USask) Vaccine…

Read More National Research Council of Canada and USasks VIDO-InterVac collaborated to advance development of vaccine against COVID-19Continue

U.S. Dept. of Veterans Affairs accepted mask donation from South Korea to assist with COVID-19 efforts
COVID-19

U.S. Dept. of Veterans Affairs accepted mask donation from South Korea to assist with COVID-19 efforts

On May 12, 2020, the U.S. Dept. of Veterans Affairs (VA) announced it had accepted a donation of…

Read More U.S. Dept. of Veterans Affairs accepted mask donation from South Korea to assist with COVID-19 effortsContinue

The Jackson Laboratory provided widescale COVID-19 testing in Connecticut
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Therapeutics | Vaccine

The Jackson Laboratory provided widescale COVID-19 testing in Connecticut

On May 12, 2020, the Jackson Laboratory (JAX), in partnership with the State of Connecticut, announced that it…

Read More The Jackson Laboratory provided widescale COVID-19 testing in ConnecticutContinue

FDA further expanded EUA for Thermo Fisher Scientific’s COVID-19 diagnostic tests
COVID-19 | FDA | Life Science History

FDA further expanded EUA for Thermo Fisher Scientific’s COVID-19 diagnostic tests

On May 12, 2020, Thermo Fisher Scientific announced the FDA has further expanded emergency use authorization (EUA) for…

Read More FDA further expanded EUA for Thermo Fisher Scientific’s COVID-19 diagnostic testsContinue

Combing through old drugs to find new ones for COVID-19
COVID-19 | Life Science History

Combing through old drugs to find new ones for COVID-19

On May 12, 2020, the Broad Instituteメs Drug Repurposing Hub announced that it had opened its repository of…

Read More Combing through old drugs to find new ones for COVID-19Continue

LabCorp significantly expanded availability of Its COVID-19 at-home collection test kit
CDC | COVID-19 | Life Science History

LabCorp significantly expanded availability of Its COVID-19 at-home collection test kit

On May 12, 2020, LabCorpᆴ announced that its COVID-19 at-home collection test kit is now being offered to…

Read More LabCorp significantly expanded availability of Its COVID-19 at-home collection test kitContinue

Mylan to supply investigational antiviral remdesivir for potential treatment of COVID-19
COVID-19 | Life Science History

Mylan to supply investigational antiviral remdesivir for potential treatment of COVID-19

On May 12, 2020, Mylan announced, as part of its ongoing efforts to support patients and public health…

Read More Mylan to supply investigational antiviral remdesivir for potential treatment of COVID-19Continue

U of Alberta pharmaceutical institute leads effort to fill looming hospital drug shortage during fight against COVID-19
COVID-19 | Life Science History

U of Alberta pharmaceutical institute leads effort to fill looming hospital drug shortage during fight against COVID-19

On May 11, 2020, a University of Alberta-initiated institute leads province wide effort to fill the looming shortage…

Read More U of Alberta pharmaceutical institute leads effort to fill looming hospital drug shortage during fight against COVID-19Continue

Bellerophon Therapeutics submited investigational NDA to study INOpulse inhaled nitric oxide for treatment of COVID-19
Biotechnology | COVID-19 | FDA | Therapeutics

Bellerophon Therapeutics submited investigational NDA to study INOpulse inhaled nitric oxide for treatment of COVID-19

On May 11, 2020, Bellerophon Therapeutics announced the FDA accepted its Investigational New Drug (IND) application, allowing the…

Read More Bellerophon Therapeutics submited investigational NDA to study INOpulse inhaled nitric oxide for treatment of COVID-19Continue

Todos Medical entered Into exclusive distribution agreement with Gnomegen and received FDA Emergency Use Authorization for COVID-19 qPCR test kits
Biotechnology | COVID-19 | Diagnostics | FDA | Medical Device

Todos Medical entered Into exclusive distribution agreement with Gnomegen and received FDA Emergency Use Authorization for COVID-19 qPCR test kits

On May 11, 2020, Todos Medical announced an exclusive distribution agreement with Gnomegen for the distribution of its…

Read More Todos Medical entered Into exclusive distribution agreement with Gnomegen and received FDA Emergency Use Authorization for COVID-19 qPCR test kitsContinue

The  FDA announced actions to accelerate development of novel prevention, treatment options for COVID-19
COVID-19 | FDA | Life Science History

The FDA announced actions to accelerate development of novel prevention, treatment options for COVID-19

On May 11, 2020, the FDA announced actions to accelerate the development of prevention and treatment options for…

Read More The FDA announced actions to accelerate development of novel prevention, treatment options for COVID-19Continue

Airway Therapeutics announced filing with NIH to evaluate AT-100 as therapy for novel Coronavirus
Biotechnology | COVID-19 | Non-Profit Research | Therapeutics

Airway Therapeutics announced filing with NIH to evaluate AT-100 as therapy for novel Coronavirus

On May 11, 2020, Airway Therapeutics announced a filing with the Respiratory Diseases Branch of the National Institutes…

Read More Airway Therapeutics announced filing with NIH to evaluate AT-100 as therapy for novel CoronavirusContinue

Page navigation

Previous PagePrevious 1 … 71 72 73 74 75 … 98 Next PageNext
  • Categories
  • Timeline
  • Agriculture
  • Artificial Intelligence
  • Biology
  • Biotechnology
  • Cardiovascular
  • Cartoons – Historical
  • Cartoons – Original
  • CDC
  • CDMO
  • Chemical
  • Clinical Research
  • Cloning
  • CMO
  • COVID-19
  • CRISPR
  • CRO
  • Cryogenic
  • Dentistry
  • Diagnostics
  • Disease
  • Energy
  • Environmental
  • EPA
  • FDA
  • Forestry
  • Genomics
  • HIV
  • Infectious Disease
  • Influenza
  • IRB
  • Life Science History
  • Marine Science
  • Materials
  • Measles
  • Medical Device
  • Medicine
  • Nanotechnology
  • Neurology
  • NIH
  • Non-Profit Research
  • Nutraceuticals
  • Oncology
  • Ophthalmogy
  • Organ Transplant
  • Orthopedic
  • Other
  • Pharmaceutical
  • Plague
  • Polio
  • Prehistory
  • Radiology
  • Rare Disease
  • Stem Cell
  • Therapeutics
  • U.S. Congress
  • Uncategorized
  • USDA
  • Vaccine
  • Veterinary
  • WHO
  • Women's Health
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • 1999
  • 1998
  • 1997
  • 1996
  • 1995
  • 1994
  • 1993
  • 1992
  • 1991
  • 1990
  • 1989
  • 1988
  • 1987
  • 1986
  • 1985
  • 1984
  • 1983
  • 1982
  • 1981
  • 1980
  • 1979
  • 1978
  • 1977
  • 1976
  • 1975
  • 1974
  • 1973
  • 1972
  • 1971
  • 1970
  • 1969
  • 1968
  • 1967
  • 1966
  • 1965
  • 1964
  • 1963
  • 1962
  • 1961
  • 1960
  • 1959
  • 1958
  • 1957
  • 1956
  • 1955
  • 1954
  • 1953
  • 1952
  • 1951
  • 1950
  • 1949
  • 1948
  • 1947
  • 1946
  • 1945
  • 1944
  • 1943
  • 1942
  • 1941
  • 1940
  • 1939
  • 1938
  • 1937
  • 1936
  • 1935
  • 1934
  • 1933
  • 1932
  • 1931
  • 1930
  • 1929
  • 1928
  • 1927
  • 1926
  • 1925
  • 1924
  • 1923
  • 1922
  • 1921
  • 1920
  • 1919
  • 1918
  • 1917
  • 1916
  • 1915
  • 1914
  • 1913
  • 1912
  • 1911
  • 1910
  • 1909
  • 1908
  • 1907
  • 1906
  • 1905
  • 1904
  • 1903
  • 1902
  • 1901
  • 1900
  • 1899
  • 1898
  • 1897
  • 1896
  • 1895
  • 1894
  • 1893
  • 1892
  • 1891
  • 1890
  • 1889
  • 1888
  • 1887
  • 1886
  • 1885
  • 1884
  • 1883
  • 1882
  • 1881
  • 1880
  • 1879
  • 1878
  • 1877
  • 1876
  • 1875
  • 1874
  • 1873
  • 1872
  • 1871
  • 1870
  • 1869
  • 1868
  • 1867
  • 1866
  • 1865
  • 1864
  • 1863
  • 1862
  • 1861
  • 1860
  • 1859
  • 1858
  • 1857
  • 1856
  • 1855
  • 1854
  • 1853
  • 1852
  • 1851
  • 1850
  • 1849
  • 1848
  • 1847
  • 1846
  • 1845
  • 1844
  • 1843
  • 1842
  • 1840
  • 1839
  • 1838
  • 1837
  • 1836
  • 1834
  • 1833
  • 1832
  • 1831
  • 1830
  • 1828
  • 1827
  • 1826
  • 1825
  • 1824
  • 1823
  • 1820
  • 1819
  • 1818
  • 1817
  • 1816
  • 1813
  • 1811
  • 1810
  • 1809
  • 1808
  • 1804
  • 1802
  • 1801
  • 1800
  • 1799
  • 1798
  • 1796
  • 1795
  • 1794
  • 1793
  • 1790
  • 1789
  • 1788
  • 1786
  • 1785
  • 1784
  • 1782
  • 1781
  • 1777
  • 1769
  • 1765
  • 1761
  • 1753
  • 1751
  • 1749
  • 1747
  • 1746
  • 1743
  • 1741
  • 1738
  • 1727
  • 1723
  • 1721
  • 1720
  • 1718
  • 1716
  • 1712
  • 1697
  • 1693
  • 1683
  • 1674
  • 1667
  • 1666
  • 1665
  • 1664
  • 1663
  • 1658
  • 1656
  • 1647
  • 1636
  • 1634
  • 1629
  • 1621
  • 1603
  • 1580
  • 1521
  • 1510
  • 1403
  • 1377
  • 1370
  • 1363
  • 1348
  • 1346
  • 1322
  • 1285
  • 1202
  • 1200
  • 1179
  • 1100
  • 1050
  • 541
  • 470
  • 1
Subscribe to E-History

Subscribe

* indicates required

LifeScienceHistory.com

LifeScienceHistory.com Where history is made daily, is a comprehensive companion of life science. Simply put, we dig history and we mine data.

More

  • About
  • Life Science Heroes

Advertising

  • Life Science Banner Advertising
  • Advertise Your Life Science Jobs

Legal

  • Privacy Policy
  • Terms of Use

© 2025 LifeScienceHistory.com by James Web Design

Facebook Instagram Linkedin
  • Home
  • Directory
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • News and History
  • Cartoons
  • Small World
  • Earth is a Rock
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
Search